Info > What's New

What's New

Please ensure you are using the most up-to-date app version of Bugs & Drugs 2.0. You should see a white “2.0” in the orange banner at the bottom of the app icon.  The 2.0 app is available free of charge from the Apple app store or Google Play.

Updated January 2023:

  1. Treatment Recommendations > Adult Patients > Skin & Soft Tissue > Animal Bites and Human Bites

Updated October 2022:

  1. Treatment Recommendations > Adult Patients > Cardiovascular > Endocarditis > Injection Drug Users (right-sided)
  2. Treatment Recommendations > Culture-Directed Infections > Endocarditis > S. aureus (right-sided/tricuspid valve)
  3. Treatment Recommendations > Adult Patients > Respiratory

Updated September 2022:

  1. Pediatric Dosing Guide and Daily Costs
  2. Adult Dosing Guide and Daily Costs
  3. IV to PO Switch Recommendations
  4. Ophthalmic Infections, Conjunctivitis, Newborn

Updated June 2022:

  1. Adult Gastrointestinal Infections empiric therapy section
  2. Culture-directed Peritoneal Dialysis (PD)-related Peritonitis section
  3. Pediatric Gastrointestinal Infections empiric therapy section

Updated May 2022:

  1. Viral keratitis in Ophthalmic Infections section

Updated March 2022:

  1. Chorioamnionitis empiric therapy section

Updated February 2022:

  1. COVID-19 Treatment Guidelines

Updated January 2022:

  1. Adult Bone & Joint Infection empiric therapy section
  2. Culture-directed Prosthetic Joint Infection section

Updated December 2021:

  1. Pediatric Bone & Joint Infection empiric therapy section
  2. Pediatric Sepsis without a focus and Sepsis empiric therapy sections

Updated November 2021:

  1. Ophthalmic Infections:  Blepharitis

Updated October 2021:

  1. COVID-19 section
  2. Treatment Recommendations, Adult, Urinary Tract, Asymptomatic Bacteriuria and Cystitis in Pregnancy – removed fosfomycin as it crosses the placenta and risk-benefit must be considered, and single dose regimens are no longer recommended in pregnancy for cystitis

  3. Dental:  please note greatly diminished role, or exclusion, of clindamycin; and addition of cefuroxime axetil as the preferred option in truly penicillin-allergic patients

  • Antimicrobial Prophylaxis in Dentistry
  • Recommended Empiric Therapy of Selected Dental Infections

Updated June 2021:

  1. Adult Clostridioides difficile infection (CDI) – oral vancomycin prophylaxis for high risk patients with recurrent CDI
  2. Prophylaxis for infective endocarditis

Updated May 2021:

  1. Cefaclor (discontinued in Canada) added to β-lactam cross-reactivity chart for patients who report an allergy in the past
  2. Changed duration of therapy for mild to moderate community-acquired pneumonia (CAP) to 3 days provided clinical stability criteria are met
  3. Changed duration of therapy for hand and wrist septic arthritis with surgical drainage to 2 weeks
  4. Adult central nervous system empiric therapy recommendations
  5. Adult meningitis culture-directed therapy recommendations
  6. Addition of culture-directed medical device-associated meningitis/ventriculitis section

Updated March 2021:

  1. Update of pediatric and adult Genital empiric therapy sections

Updated January 2021:

  1. Neonatal/pediatric central nervous system empiric therapy recommendations
  2. Spectrum of activity of doxycycline, macrolides, and quinolones for Mycoplasma and Ureaplasma spp
Content Version: 0.0.137 Jan 27, 2023.08:17
©1998-2020 Alberta Health Services